New Educational Resource for Clinicians—Opioid Dosage & Morphine Equivalency
Read SPPAN’s first resource in a series, Opioid Dosage & Morphine Equivalency: Implications for Meeting the Standard of Care when Comparing CDC Recommendations to State Policies. This tool examines the US Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain, and its effect on a variety of important clinical practice issues. Our goal is to help prescribers better understand how the CDC guideline’s recommendations match or conflict with state policy.
Must Read: Pay for Integrative Pain Care–AIPM’s Past President Powerful Op-Ed in USA Today
The juxtaposition highlighted in Dr. Bonakdar’s USA Today Op-Ed—receiving the Surgeon General’s letter as part of the “Turn the Tide” initiative on the same day that the author received two denials from two different insurance companies for biofeedback and acupuncture—is powerful, to say the least.
AIPM Executive Director Involved in Programs to Address Two Public Health Crises
AIPM Executive Director Bob Twillman recently spoke to groups in Illinois and Nevada about the challenges inherent in addressing two concurrent public health crises—prescription opioid abuse and chronic pain. The key point of the presentations was that using an integrative approach to pain management is one way to address both problems simultaneously without worsening either. Challenges to implementing this approach were highlighted, with a call for attendees to support policy changes to overcome those challenges.
SPPAN Director Advocates for Needs of People with Pain at NY’s MedTech
It was refreshing to see this panel included in MedTech’s annual meeting, Innovation Impact: Keeping New York’s Finger on the Pulse. On September 27, Amy Goldstein, SPPAN Director, along with Charles Argoff, MD, and Scott Kelley, MD, were panelists as Mario Nacinovich, M.Sc., moderated “Feeling the(ir) Pain: Understanding Patient Needs as a Crucial Way Forward in Ending the Opioid Epidemic” Ms. Goldstein and Drs. Argoff and Kelley, shared the realities of how simple solutions for complex issues can lead to unintended consequences. For example, without focused education and training early-on around integrative, multidisciplinary pain care, clinicians do not have a full toolbox at the ready to care for their patients.
Vermont Considering Significant Changes to Rules Governing PMP and Opioid Prescribing
The Vermont Department of Health is considering substantial proposed revisions to rules concerning both the Vermont Prescription Monitoring System and the Prescribing of Opioids for Pain. Both proposed rules, if finalized as written, will significantly change current law, affecting both those living with pain and the prescribers who care for them. Both proposed rules are scheduled for hearing on October 21st; further, both proposed rules will be accepting written comments until October 28th.
National Pain Strategy–Public Access Upcoming Meeting
The Interagency Pain Research Coordinating Committee (IPRCC) meeting scheduled for October 31, 2016, will be open to the public and accessible by live webcast and conference call. The meeting will feature invited speakers and discussions of committee business items including a progress report on implementation of the National Pain Strategy, updates on the Federal Pain Research Strategy, and new pain initiatives. Notification of intent to present oral comments must be submitted to submitted to Linda Porter, Ph.D, at Linda.Porter@nih.gov, no later than October 17, 2016, and deadline for written/electronic statement by October 24, 2016.
If you have any questions or comments about any of the above information, contact us at: